On February 12, 2024, Evaxion Biotech (NASDAQ:EVAX) caught the attention of HC Wainwright & Co. analyst Swayampakula Ramakanth, who initiated ...
Evaxion Biotech A/S (NASDAQ:EVAX) has successfully fulfilled the minimum bid price requirement outlined by the Nasdaq Listing Rule 5550(a)(2), marking ...
On January 22, 2024, Evaxion Biotech A/S (NASDAQ: EVAX) shares were once again available for trading. The stock had closed ...
Evaxion Biotech A/S, a pioneering biotech company, is at the forefront of developing innovative cancer vaccines using their groundbreaking AI-Immunology™ ...
On January 22, 2024, when a trading halt is implemented, it temporarily suspends trading activities for a specific stock. This ...
